The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

21
The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

description

The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome. Thank you for taking the pre-assessment. These questions will be repeated at the end of the activity. CHAMPION Trials: Study Designs. CHAMPION Trials Primary End Point and Stent Thrombosis. - PowerPoint PPT Presentation

Transcript of The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Page 1: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

The Role of Intravenous and Oral Antiplatelet Agents in Acute

Coronary Syndrome

Page 2: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Thank you for taking the pre-assessment.

These questions will be repeated at the end of the activity.

Page 3: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

CHAMPION Trials: Study Designs

Page 4: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

CHAMPION Trials Primary End Point and Stent Thrombosis

Page 5: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Antiplatelet Therapy in ACS

Page 6: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

ADP Receptor Antagonists in ACS

Page 7: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome
Page 8: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

2013 ACCF/AHA Guideline for STEMI

Page 9: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome
Page 10: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome
Page 11: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

ARCTIC No Advantage With Platelet Function- Guided

Therapy

Page 12: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Glycoprotein IIb/IIIa vs Cangrelor

Page 13: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Pooled CHAMPION TrialsDeath, MI, IDR, Stent Thrombosis

Page 14: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Pooled CHAMPION Trials (cont)Death, MI, IDR, Stent Thrombosis in Subgroups

Page 15: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome
Page 16: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Pooled CHAMPION TrialsNon-CABG Bleeding at 48 h, Safety

Page 17: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Abbreviations

Page 18: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

Abbreviations (cont)

Page 19: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

References

Page 20: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

References (cont)

Page 21: The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

References (cont)